medigraphic.com
ISSN 2954-3835 (Electronic)
ISSN 2683-2828 (Print)

2020, Number S3

<< Back Next >>

Cardiovasc Metab Sci 2020; 31 (S3)

Care of acute coronary syndromes during the health contingency due to a SARS-CoV-2 outbreak

Piña-Reyna Y, García-Rincón A, Ortiz-Fernández PH, Gutiérrez-Fajardo P, Alcocer-Gamba MA, Merino-Rajme JA, Reyes-Terán G

Language: Spanish
References: 3
Page: 197-198
PDF size: 157.56 Kb.


ABSTRACT

The communications accumulated in the last weeks make it clear that there is no agreement to define the best treatment strategy in patients with acute coronary syndrome (SICA). In patients presenting with an acute myocardial infarction with ST-segment elevation (IAMCESST), it has been suggested to favor fibrinolysis (FL) over primary percutaneous coronary intervention (PCI), reserving ICP for cases of failed FL; however, some societies have maintained the indication of the ICPp as the repercussion method of choice. In SICAs without ST segment elevation (SICASESST) the recommendations are very similar, favoring medical treatment over percutaneous coronary intervention in this subgroup of patients. Several companies consider the contagion status, particularly in the SICASESST, to decide which repercussion follow. Anticipating that the epidemiological curve in Mexico will be similar to that observed in most countries, we recommend continuing the care of patients with SICA, the catheterization rooms must maintain their operation.


REFERENCES

  1. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital [published online ahead of print, 2020 Mar 11]. Intensive Care Med. 2020; 1-3.

  2. Welt FGP, Shah PB, Aronow HD et al. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020. https://doi. org/10.1016/j.jacc.2020.03.021

  3. Romaguera R, Cruz-González I, Jurado-Román A et al. Consideraciones sobre el abordaje invasivo de la cardiopatía isquémica y estructural durante el brote de coronavirus COVID-19. Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación de Cardiopatía Isquémica y Cuidados Agudos Cardiovasculares de la Sociedad Española de Cardiología. REC Interv Cardiol. 2020. https://doi. org/10.24875/RECIC.M20000119




2020     |     www.medigraphic.com